Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 16.12.2021.

#biopharma
#businessnews
#data
#biotech
#biosciences
#COVID19
#GoodDayBIO

Career And Jobs

@biospace shared
On Dec 11, 2021
Three more biopharma expansions to round out the week #biopharma #businessnews https://t.co/4Fx4BG2qRl
Open
Three More Biopharma Expansions to Round Out the Week

Three More Biopharma Expansions to Round Out the Week

Innocoll Biotherapeutics, Genapsys, and Adicet Bio announced today their relocation and expansion plans.

@JohnCendpts shared
On Dec 10, 2021
Another excellent report from the Peer Review team: Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive https://t.co/ZQ8rSfZARx
Open
Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive

Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive

Margaret Koziel has bounced back and forth between academia and biotech throughout her career — and after 25 years, she has landed her first position as part of a biotech's top brass. ...

@FierceBiotech shared
On Dec 13, 2021
Tidy up your labs, biotech. @pfizer is coming with ‘significant firepower’ and cash to burn $PFE https://t.co/i1sUsQF28H
Open
Tidy up your labs, biotech. Pfizer is coming with 'significant firepower' and cash to burn

Tidy up your labs, biotech. Pfizer is coming with 'significant firepower' and cash to burn

Inquiring minds have wanted to know: what does Pfizer, loaded up with buckets of cash from the successful COVID-19 vaccine Comirnaty, want to buy? Executives gave a preview of what else ...

@IAmBiotech shared
On Dec 15, 2021
New op-ed by @TakedaPharma President of R&D, Andy Plump, on how the #biopharma industry can maintain growing public trust in science: “We must continue to build on this foundation of trust in the future by continuing to focus on and serve patients.” https://t.co/JN3QvrPFEp
Open
Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help

Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help

Against declining trust in traditional news sources and institutions that provide data and information, the results of a new poll are both gratifying and a call to action for everyone ...

@FierceBiotech shared
On Dec 15, 2021
AbbVie ends enrollment in Idera collab as the biotech winds down its own colorectal cancer trial $ABBV https://t.co/AnqN8vX4WJ
Open
AbbVie ends enrollment in Idera collab as the biotech winds down its own colorectal cancer trial

AbbVie ends enrollment in Idera collab as the biotech winds down its own colorectal cancer trial

Idera Pharmaceuticals will no longer enroll patients in a midstage study of its drug in colorectal cancer, and AbbVie decided to do the same in an early stage test in head and neck cancer.

@biospace shared
On Dec 15, 2021
Set your data management strategy early for long-term biotech success #data #biotech https://t.co/yZQ7y9XDs8
Open
Set Your Data Management Strategy Early for Long-term Biotech Success

Set Your Data Management Strategy Early for Long-term Biotech Success

Good data management means developing a systematic way to integrate and update data enterprise-wide and to share it with team members or partners as needed.

@SynBioBeta shared
On Dec 11, 2021
.@breakout_vc, a San Francisco-based seed-stage venture firm that funds what it calls creative #biosciences startups, has closed the second fund in its five-year history with $112.5 million in capital commitments. https://t.co/1v3CzgGNOS
Open
Breakout Ventures has a new, $112.5 million fund, backed by Tony Fadell, Chris Sacca, and others

Breakout Ventures has a new, $112.5 million fund, backed by Tony Fadell, Chris Sacca, and others

Breakout Ventures, a San Francisco-based seed-stage venture firm that funds what it calls creative biosciences startups, has closed the second fund in its five-year history with $112.5 ...

@IAmBiotech shared
On Dec 13, 2021
#GoodDayBIO: One year after authorization of #COVID19 vaccines, hesitancy remains a challenge. Plus, a deep dive in the plastic problem plaguing our oceans and how biotech can help solve it. https://t.co/lLh7TTPSKq
Open
Good Day BIO: One year after authorization of vaccines, hesitancy remains a challenge

Good Day BIO: One year after authorization of vaccines, hesitancy remains a challenge

Starting a new week with another important anniversary in the COVID-19 timeline, as well as a deep dive in the plastic problem plaguing our oceans (and how biotech can help solve it). ...